Virtual Program
Accreditation Statements
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Association of Pathologists. You may claim a maximum of 17.5 hours. Credits are automatically calculated.
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Association of Pathologists. You may claim a maximum of 3.5 hours. Credits are automatically calculated.
There are 8 sessions with SAQs. Each questions is considered 10 minutes of assessment for a total of 3.5 hours in Section 3. To qualify for Section 3 credits, participants must complete the pre-test, attend the course and complete the post test.
Earn Up to 3.5 Hours Section 3
Complete the pre and post test and participate in the Banff Course to qualify for Section 3 MOC.
This program is in Mountain Time/Alberta (not Eastern Time (Toronto)!)
Wed. Sept 8
| Wednesday - Resident Leadership | |
| 0900-1330 | Resident Leadership Focus Day 0900-1100: Informatics & Data Management** - Speakers: Chris Naugler, Etienne Mahe (Mole & GP), Susan Nahirniak (HemeP & Transfusion) & David Beyer (GP Grad - Susan is his fellowship director) Includes: Resident research or research methodologies, data management, Connect Care or AHS 1100-1130: Break 1130-1330: Quality Assurance/ assessment / PSQA |
Thurs. Sept 9
|
Thursday - Lymph Node Pathology |
|
| 0800-0815 | Introductory Remarks & Welcome Dr. Michael Mengel (University of Alberta) Dr. Hallgrimur Benediktsson (University of Calgary) |
|
Session 1 – Moderator: Dr. Meer-Taher Shabani-Rad (University of Calgary) |
|
| 0815-0900 | Keynote - Updates in WHO Classification of B-cell Lymphoma: A Practical Perspective Dr. Megan Lim (University of Pennsylvania) |
| 0900-0930 | Diagnosis and Workup of Aggressive B-cell Lymphomas Dr. Megan Lim (University of Pennsylvania) |
| 0930-1000 | New Era of Core Lymph Node Biopsies: Review of the New Alberta Health Services Protocol *Section 3 Accredited Activity with Pre & Post Tests* Dr. Doug Stewart (University of Calgary) |
| 1000-1030 | Break |
|
Session 2 – Moderator: Dr. Iwona Auer (University of Calgary) |
|
| 1030-1100 | Lymphoma Diagnosis in the Era of Needle Core Biopsies: Challenges and Pitfalls Dr. Megan Lim (University of Pennsylvania) |
| 1100-1130 | Splenic B cell lymphoma diagnosis Dr. Nathanael Bailey, University of Pittsburgh |
| 1130-1200 | Discussion and Question & Answer Period |
| 1200-1400 | Practical Approach to the Diagnosis of T Cell Lymphoma Dr. Jonathan Said (University of California Los Angeles) |
|
Session 3 – Moderator: Dr. Adnan Mansoor (University of Calgary) |
|
| 1400-1430 | Updates in Pediatric Lymphoma Dr. Megan Lim (University of Pennsylvania) |
| 1430-1500 | Infectious Diseases In Lympohreticular Pathology *Section 3 Accredited Activity with Pre & Post Tests* Dr. Gareth Turner (University of Oxford) |
| 1500-1530 | Break |
|
Session 4 – Moderator: Dr. Afshin Shameli (University of Calgary) |
|
| 1530-1615 | Division of Hematopathology Case Presentations (3 cases, 15 minutes/case) *Section 3 Accredited Activity with Pre & Post Tests* |
| 1615-1700 | Keynote - Diagnostic Pitfalls in Lymphoma Diagnosis Dr. Jonathan Said (University of California Los Angeles) |
Fri. Sept 10
| Friday - Molecular Pathology | |
| 0800-0815 | Introductory Remarks & Welcome Dr. Michael Mengel (University of Alberta) Dr. Hallgrimur Benediktsson (University of Calgary) |
|
Session 1 – Moderator: Dr. Faisal Khan (University of Calgary) |
|
| 0815-0900 | Keynote - New Developments in Molecular Testing of Lymphoma Dr. Nathanael Bailey, University of Pittsburgh |
| 0900-0930 | Improving the Molecular Characterization of Myeloid Neoplasms Dr. Etienne Mahe (University of Calgary) |
| 0930-1000 | Immunogenetic Landscape of Hematological Malignancies and Hematopoietic Stem Cell Transplantation *Section 3 Accredited Activity with Pre & Post Tests* Dr. Faisal Khan (University of Calgary) |
| 1000-1030 | Break |
|
Session 2 – Moderator: Dr. Etienne Mahe (University of Calgary) |
|
| 1030-1100 | Role of Surgical Pathologist in Molecular Diagnostic Testing *Section 3 Accredited Activity with Pre & Post Tests* Dr. Iyare Izevbaye (University of Alberta) |
| 1100-1130 | NA Mismatch Repair and Microsatellite Instability: Practical Considerations in Molecular Testing of Colorectal Tumors *Section 3 Accredited Activity with Pre & Post Tests* Dr. Cheryl Mather (University of Alberta) |
| 1130-1200 | Testing for BRCA1/2 and Homologous Recombination Deficiency in Ovarian Cancer: Standard of Care Dr. Soufiane El-Hallani (University of Alberta) |
| 1200-1230 | Cancer Cytogenomics Dr. Bob Argiropoulos (University of Calgary) |
|
Session 3 – Moderator: Dr. Cheryl Mather (University of Alberta) |
|
| 1230-1300 | Integrating Pathology and Molecular Diagnostics for Pulmonary Neoplasms *Section 3 Accredited Activity with Pre & Post Tests* Dr. Adrian Box (University of Calgary) Dr. Angela Franko (University of Calgary) |
| 1300-1400 | Molecular Testing of Cytology Specimens *Section 3 Accredited Activity with Pre & Post Tests* Dr. Remegio Maglantay (University of Alberta) |
Sat. Sept 11
|
Saturday - Molecular Pathology, Genetics & Genomics |
|
| 0800-0815 | Introductory Remarks & Welcome Dr. Michael Mengel (University of Alberta) Dr. Hallgrimur Benediktsson (University of Calgary) |
|
Session 1 – Moderator: Dr. Imran Mirza (University of Calgary) |
|
| 0815-0900 | Discussion Forum Molecular Pathology/Genomics Education Opportunities for Residents and Pathologists Dr. Adrian Box (University of Calgary) – Moderator Dr. Jillian Parboosingh (University of Calgary) Dr. Dennis Bulman (University of Calgary) |
| 0900-0930 | Molecular autopsies in sudden death cases: a multi-discipline approach to
implementing NGS testing for Inherited Cardiac Disorders Dr. Sherry Taylor (University of Alberta) |
| 0930-1000 | Direct to Consumer Genetic Testing: Issues and Challenges Dr. Jillian Parboosingh (University of Calgary) |
|
Session 2 – Moderator: Dr. Iyare Izevbaye (University of Alberta) |
|
| 1000-1015 | Break |
| 1015-1130 | Ethical Considerations in Testing and Reporting in Molecular Genetic Pathology Dr. Dennis Bulman (University of Calgary) |
| 1130-1200 | Interpreting Molecular Genetic Pathology Reports Dr. Imran Mirza (University of Calgary) |
| 1200-1215 | Closing Remarks Dr. Michael Mengel (University of Alberta) Dr. Hallgrimur Benediktsson (University of Calgary) |